Compile Data Set for Download or QSAR
Report error Found 31 Enz. Inhib. hit(s) with all data for entry = 13159
TargetTyrosine-protein kinase BTK [C481S](Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764315(4-(4-amino-3-(4-(2-fluoro-3-methoxyphenoxy)phenyl)...)
Affinity DataIC50: 0.600nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764304(US12384786, Example 8A)
Affinity DataIC50: 0.700nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764310((1s,4s)-4-(4-amino-3-(4-(2-fluoro-3-methoxyphenoxy...)
Affinity DataIC50: 0.900nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764321((1S,3S)-3-(4-amino-3-(4-(2-fluoro-3-methoxyphenoxy...)
Affinity DataIC50: 0.900nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764312(3-(4-amino-3-(4-(2-fluoro-3-methoxyphenoxy)phenyl)...)
Affinity DataIC50: 1nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764319(US12384786, Example 30 Peak2-1)
Affinity DataIC50: 1.10nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764305((1R,3R)-3-(4-amino-3-(4-(3-fluorophenoxy)-1H-pyraz...)
Affinity DataIC50: 1.70nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764315(4-(4-amino-3-(4-(2-fluoro-3-methoxyphenoxy)phenyl)...)
Affinity DataIC50: 1.70nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764319(US12384786, Example 30 Peak2-1)
Affinity DataIC50: 1.80nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764304(US12384786, Example 8A)
Affinity DataIC50: 2.5nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764321((1S,3S)-3-(4-amino-3-(4-(2-fluoro-3-methoxyphenoxy...)
Affinity DataIC50: 2.60nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764320(US12384786, Example 30-Peak2-2)
Affinity DataIC50: 2.80nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764303((1R,3R)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazole...)
Affinity DataIC50: 3.40nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764312(3-(4-amino-3-(4-(2-fluoro-3-methoxyphenoxy)phenyl)...)
Affinity DataIC50: 3.5nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764317(US12384786, Example 30 Peak1-1)
Affinity DataIC50: 3.70nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764305((1R,3R)-3-(4-amino-3-(4-(3-fluorophenoxy)-1H-pyraz...)
Affinity DataIC50: 3.80nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764317(US12384786, Example 30 Peak1-1)
Affinity DataIC50: 3.80nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764310((1s,4s)-4-(4-amino-3-(4-(2-fluoro-3-methoxyphenoxy...)
Affinity DataIC50: 5nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764320(US12384786, Example 30-Peak2-2)
Affinity DataIC50: 5nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764318(US12384786, Example 30 Peak1-2)
Affinity DataIC50: 6.70nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764303((1R,3R)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazole...)
Affinity DataIC50: 8.10nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764318(US12384786, Example 30 Peak1-2)
Affinity DataIC50: 8.5nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764313((+-) trans-3-(4-amino-3-(4-(2-fluoro-3-methoxyphen...)
Affinity DataIC50: 14.3nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764311((1r, 4r)-4-(4-amino-3-(4-(2-fluoro-3-methoxyphenox...)
Affinity DataIC50: 16nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764306((1R, 3R)-3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)-1...)
Affinity DataIC50: 18.8nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764322((1R,3R)-3-(4-(4-amino-1-(3-hydroxycyclohexyl)-1H-p...)
Affinity DataIC50: 19.2nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764307((1R,3R)-3-(4-amino-3-(4-(2-fluorophenoxy)phenyl)-1...)
Affinity DataIC50: 24.1nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764309((1R, 3R)-3-(4-amino-3-(4-(2-fluoro-3-methoxyphenox...)
Affinity DataIC50: 24.9nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764314(3-(4-amino-3-(4-(3-fluorophenoxy) phenyl)-1H-pyraz...)
Affinity DataIC50: 26.9nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764308((1R, 3R)-3-(4-amino-3-(4-(2,6-difluorophenoxy)phen...)
Affinity DataIC50: 49.1nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Minghui Pharmaceutical (Shanghai)

US Patent
LigandPNGBDBM764316(US12384786, Example 29)
Affinity DataIC50: 64.1nMAssay Description:The BTK/BTK (C481S) inhibitory activity of compound of formula A was determined in Reaction Biology Corporation, One Great Valley Parkway, Malvern, P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent